INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Bank Ltd INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Clarification sought from Indraprastha Medical Corporation Ltd
The Exchange has sought clarification from Indraprastha Medical Corporation Ltd on April 5, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
Indraprastha Medical Corp hits 52-week high after HDFC Bank sells 27.8 lakh shares
HDFC Bank sold 3.03 percent of the total share capital of Indraprastha Medical Corporation, for an all cash consideration of Rs 55.46 crore. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Resignation of Director
This is to inform you that Mr. Vikram Bhat (DIN 09076418) has tendered his resignation (vide email dated 28th March, 2024) as Non- Executive Director (Nominee Director- Govt. of NCT of Delhi- Promoter of the Company) with effect from 28th March, 2024. The details as required under SEBI Circular is enclosed herewith. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate
We hereby inform you that Mr. S Regunathan (DIN 00286505), Mr. Deepak Vaidya (DIN 00337276) and Mr. Satnam Arora (DIN 00010667) have completed their tenure viz. second term of 5 consecutive years on 31st March, 2024, as an Independent Director on the Board of Directors of the Company. The details as required under SEBI Circular are enclosed herewith. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
we hereby submit copies of the public notice of the Postal ballot, Published on 23rd March, 2024, in the "Financial Express", all India editions, and in "Jansatta", Delhi edition. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window
it is hereby to inform that Trading Window for dealing in shares of the company, shall remain closed with effect from 1st April,2024 till 48 hours after the declaration of audited financial results for the year ending 31st March, 2024. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
we hereby enclose a copy of the Postal Ballot Notice for seeking Approval of its members by way of Postal Ballot voting (only through E-voting) for the businesses as set out in the Postal Ballot notice dated 7th March,2024 Postal Ballot Notice is being sent by e-mail only to those members who gave have registered their e-mail addresses with the company''s Registrar and Share Transfer Agent or their respective Depository Participants as Friday, 15th March,2024(Cut-off date). In accordance with the provisions of MCA circulars, hard copy of Postal Ballot Notice along with Postal Ballot Forms and pre-paid business envelop will not be sent to the members and the members are required to communicate their assent or dissent through e-voting system only. The company has engaged the services of NSDL for the purpose of providing e-voting facility. The voting will start from Tuesday,26th March,2024 (9:00 AM)and shall end on Wednesday, 24th April, 2024 (5:00 PM). INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that the Company has issued duplicate share certificates in respect of share certificates reported to be lost by the shareholders. The details of the said share certificates enclosed herewith. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate
This is to inform you that the board of directors on the recommendation of the Nomination and Remuneration committee has today i.e., 07.03.2024, considered and approved the appointment of Mr. Tejpreet Singh Chopra (DIN 00317683), as an independent director for the term of 5 years from 1st April, 2024, to 31st march, 2029, subject to the approval of shareholders.